Tag: adrenoleukodystrophy
Poxel announces its participation in conferences organized by patient associations in the field of adrenoleukodystrophy – 06/15/2023 at 07:30
LYON, France, June 15, 2023 – POXEL SA (Euronext: POXEL – FR0012432516), a clinical-stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH)…